Letters in Drug Design & Discovery

ISSN: 1570-1808 - Expanded Frequency Online - Now 8 Issues in 2008

Editor in Chief:

Atta-ur-Rahman, FRS
HEJ Research Institute of Chemistry
University of Karachi
Karachi-75270
Pakistan

Associate Editors:

H. -Y. Koh (Korea Inst. of Science and Technology, Seoul, Korea)
Y. Kurogi (Cambridge Isotope Laboratories, Inc., Andover, MA, USA)
E.J. LaVoie (The State Univ. of New Jersey, New Jersey, USA)
K. Maiese (Wayne State University, Detroit, MI, USA)
A. Makriyannis (University of Connecticut Storrs, CT, USA)
J.J. Nestor, Jr. (Sequenom Pharmaceuticals, San Diego, CA, USA)
B. Wang (Georgia State University, Atlanta, GA, USA)
D.J. Waxman (Boston University, Boston, MA, USA)

Regional Editors:

S. Ahmed (Kingston University, Surrey, UK)
J.F. Honek (University of Waterloo, Ontario, Canada)
Y. Okada (Kobe Gauin University, Nishi-ku, Japan)
J.L. Neumeyer (McLean Hospital, Belmont, MA, USA)

Editorial Advisory Board:

S.S. Abdel-Meguid (Suntory Pharma. Res. Lab. LLC, Cambridge, MA, USA)
J.D. Adams, Jr. (Univ. of Southern California, Los Angeles, CA, USA)
J. Alvarez-Builla (G., Universidad de Alcalá, Madrid, Spain)
O.A.C. Antunes (Instituto de Química, Rio de Janeiro, Brazil )
M. Asanuma (Okayama Univ. Grad. Sch. Med. & Dent., Okayama, Japan)
J. Baranowska-Kortylewicz (University of Nebraska, NE, USA)
E.J. Barreiro (Universidade Federal do Rio de Janeiro, RJ, Brazil)
D.B. Berkowitz (University of Nebraska, Lincoln, NE, USA)
T. Burke (National Cancer Institute, Frederick, MD, USA)
F.P. Bymaster (Lilly Research Laboratories, Indianapolis, IN, USA)
E.V. Babaev (Moscow State University, Mascow, Russia)
F.C. Barone (GlaxoSmithKline, King of Prussia, PA, USA)
F.I. Carroll (Research Triangle Institute, NC, USA)
B.K. Cassels (Universidad de Chile, Santiago, Chile)
C.H. Chen (Duke University Medical Center, Durham, NC, USA)
P.A. Cole (Johns Hopkins University, Baltimore, MD, USA)
J.Conn (Merck Research Laboratories, West Point, PA, USA)
M. Crider (Southern Illinois University Edwardsville, Edwardsville, IL, USA)
X. Chen (AtheroGenics, Inc., Alpharetta, GA, USA)
D. Colomer (Unitat D'hematopatologia, Barcelona, Spain)
W.-M. Dai (The Hong Kong Univ. of Sci. and Tech., Hong Kong, China)
D.R. Davis (University of Utah, Salt Lake City, UT, USA)
E.B. Desouza (Archemix Corporation, Cambridge, NA, USA)
J.W. Ellingboe (Wyeth Research, Pearl River, NY, USA)
D.K. Ferris (NCI-Frederick Cancer Res. & Dev. Center, Frederick, MD, USA)
H.C. Fibiger (Eli Lilly and Company, Indianapolis, IN, USA)
A.J. Fischman (Massachusetts General Hospital, Boston, MA, USA)
D. Flynn (Neogenesis Pharmaceuticals Inc., Cambridge, MA, USA)
K.R. Fox (University of Southampton, Southampton, UK)
F.K. Friedman (National Cancer Institute, Bethesda, MD, USA)
E.P. Garvey (GlaxoSmithKline, Research Triangle Park, NC, USA)
M.A. Geyer (University of California San Diego, La Jolla, CA, USA)
D.S. Goodsell (The Scripps Research Institute, La Jolla, CA, USA)
S. Guccione (University of Catania, Catania, Italy)
E. Garattini (Instituto di Ricerche Farmacologiche, Milan, Italy)
S.P. Gupta (Birla Institute of Technology and Science, Pilani, India)
A. Harvey (University of Strathclyde, Glasgow, UK)
F.F. Hefti (Rinat Neuroscience Corporation, South San Francisco, CA, USA)
J.D.M. Herscheid (VU University Medical Center, Amsterdam, The Netherlands)
J. Haveman (University of Amsterdam, Amsterdam, The Netherlands)
H.N. Jayaram (Indiana University School of Medicine, Indianapolis, IN, USA)
A.Y. Jeng (Novartis Pharmaceuticals Corp., East Hanover, NJ, USA)
K.-T. Jeang (Molecular Virology Section, Bethesda, MD, USA)
M. Kahn (University of Washington, Seattle, WA, USA)
M. Kassiou (Royal Prince Alfred Hospital, Camperdown, Australia)
T.H. Koch (University of Colorado at Boulder, CO, USA)
H. Kubinyi (Donnersbergstrasse 9, Weisenheim am Sand, Germany)
A.V. Kalueff (National Institute of Mental Health, Bethesda, MD, USA)
A. Kamal (Indian Institute of Chemical Technology, Hyderabad, India)
H.J. Koch (Psychiatrische Universitatklinik, Regensburg, Germany)
P.Y. Lam (Bristol-Myers Squibb Co., Princeton, NJ, USA)
J. Lee (Seoul National University, Seoul, Korea)
H. LeVine (Pfizer Global Research & Development, Ann Arbor, MI, USA)
A.J. Lewis (Signal Res. Division of Celgene, San Diego, CA, USA)
B.T. Liang (University of Connecticut Health Center, Farmington, CT, USA)
G.K. Lloyd (Nereus Pharmaceuticals Inc, San Diego, CA, USA)
T. Loftsson (University of Iceland, Reykjavik, Iceland)
S. Lang (Technical Services & Operational Excellence, Costa Mesa, CA , USA)
W. Le (Baylor College of Medicine, Houston, TX, USA)
J.T.M. Linders (Johnson & Johnson Pharm. Res. & Develop., Beerse, Belgium)
R. Mairs (University of Glasgow, Glasgow, UK)
J.E. Manson (Brigham and Women's Hospital, Boston, MA, USA)
B.E. Maryanoff (Johnson & Johnson Pharmaceuticals. Res. & Dev., PA, USA)
R. P. Mason (Univ. Texas Southwestern Medical Ctr., Dallas, TX, USA)
S. Mehta (Matinal Circle, San Diego, CA, USA)
S. Mobashery (University of Notre Dame, Notre Dame, IN, USA)

C.B. Marsh (Ohio State University, Columbus, OH, USA)
G. Mccleane (Rampark Pain Center, Lurgan, Ireland)
P.A. Newhouse (University of Vermont, Burlington, VT, USA)
A.H. Newman (National Institutes of Health, Baltimore, MD, USA)
F.G. Njoroge (Schering-Plough Research Institute, Kenilworth, NJ, USA)
D.A. Nugiel (Bristol-Myers Squibb, Wilmington, DE, USA)
G. Naray-Szabo (Eötvös Loránd University, Pazmany Hungary)
I. Ojima (State University of New York, Stony Brook, NY, USA)
D.F. Ortwine (Pfizer Global Res. & Dev., Ann Arbor, MI, USA)
J. Pearlman (Dartmouth Medical School, NH, USA)
L.M. Pelus (Indiana University, Indianapolis, IN, USA)
G. Perry (University of Texas, San Antonio, Texas, USA)
E. Pop (Alchem Laboratories Corporation, FL, USA)
M. Pascu (Biomedicine and Molecular BioSciences, Brussels, Belgium)
J.E. Rice (Rutgers University, Piscataway, NJ, USA)
K.C. Rice (National Institute of Health, Bethesda, MD, USA)
P.D. Roepe (Georgetown University, Washington, DC, USA)
A W. Root (Univ. of South Florida, St. Petersburg, FL, USA)
D.P. Rotella (Bristol-Myers Squibb, Princeton, NJ, USA)
T.K. Sawyer (ARIAD Pharmaceuticals, Cambridge, MA, USA)
R.B. Silverman (Northwestern University, Evanston, IL, USA)
N.E. Sladek (University of Minnesota, Minneapolis, MN, USA)
D.S. Soriano (University of Pittsburgh-Bradford, Bradford, PA, USA)
R. Sabatowski (University of Cologne, Koln, Germany)
D. Stahl (Institute for Transfusion Medicine, Munster, Germany)
R.E. Tanzi (Massachusetts General Hospital, Charlestown, MA, USA)
A. Toninello (Università degli Studi di Padova, Padova, Italy)
G.P. Tuszynski (Temple University, Phila, PA, USA)
H.F. VanBrocklin (Lawrence Berkeley National Lab., Berkeley, CA, USA)
C.D. Wegner (Pfizer Global R&D, St. Louis, MO, USA)
R.L. White (Dalhousie University, Nova Scotia, Canada)
J.S. Williamson (University of Mississippi, MS, USA)
L. Yang (Merck Res. Lab., Rahway, NJ, USA)
Z.-J. Yao (Shanghai Institute of Organic Chemistry, Shangai, China)
R. Zhang (University of Alabama, Birmingham, AL, USA)